PRIMARY DOCUMENT

Company

Monopar Therapeutics

Filed

April 29, 2020

Period of Report

June 11, 2020

Accession Number

0001654954-20-004608

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →